
Sign up to save your podcasts
Or


Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-12704 / July 2025
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Pfizer3
11 ratings
Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-12704 / July 2025
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2,103 Listeners

601 Listeners

79 Listeners

416 Listeners

827 Listeners

237 Listeners

371 Listeners

990 Listeners

140 Listeners

733 Listeners

27 Listeners

28 Listeners

93 Listeners

3,037 Listeners

968 Listeners

871 Listeners

0 Listeners

0 Listeners

124 Listeners

301 Listeners

0 Listeners

0 Listeners